Starbucks: Analysts Expect Q1 Revenues Of $7.95 Billion

Starbucks (NASDAQ: SBUX) will be reporting its first quarter financial results on February 1st before the market opens. Analysts have a consensus $121.97 12-month price target on the company, via a total of 37 analysts, with 9 analysts having strong buy ratings.

Nine analysts meanwhile have buy ratings, 18 analysts have a hold rating and a single analyst has a strong sell rating on the company. The street high comes from Kalinowski Equity Research with a $148 price target, and the lowest target sits at $96.

26 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 26 analysts is $7.95 billion; this number has been flat since October 30th. The highest revenue estimate is $8.18 billion, while the lowest is $7.4 billion.

Onto EBITDA estimates, there are currently 18 analysts who have first-quarter EBITDA estimates. The mean is currently $1.66 billion, with this number having been revised downwards from $1.71 billion at the end of October. The street high estimate currently sits at $1.82 billion in EBITDA and the lowest is $1.49 billion.

Analysts estimate that quarterly earnings per share will come in at $0.80, with this number flat since the end of October. The street high sits at $0.90 and the lowest estimate is $0.72 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Copper Is Heading To $30 And Silver To $200 | Craig Parry

Mako Mining Q3 Earnings: The Transitional Quarter

B2Gold Q3 Earnings: Goose Troubles Cloud The Narrative

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

PI Financial, Canaccord Revise Cronos Group Estimates Downward Following Q3 Results

Last week, Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its third quarter 2020 results. The...

Sunday, November 8, 2020, 11:39:00 AM

BMO: Investors Remain Underweight In Base & Precious Metals

BMO Capital Markets Metals & Mining analysts recently met with several U.S investors, both long...

Sunday, September 18, 2022, 05:17:00 PM

Aphria: Canaccord, PI Financial Reiterate Ratings And Price Targets After Q1 Financials

Yesterday, Aphria Inc (TSX: APHA) (NASDAQ: APHA) released its fiscal first quarter results. Net revenue...

Friday, October 16, 2020, 10:09:53 AM

Uranium Energy: Canaccord Lifts Rating To Speculative Buy

Last Monday, Uranium Energy Corp (NYSE: UEC) announced that they would be acquiring UEX Corporation...

Tuesday, June 21, 2022, 10:27:00 AM

Medipharm Labs: Canaccord Lowers Targets After Earnings

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company...

Friday, August 20, 2021, 07:54:00 AM